FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884594923> ?p ?o ?g. }

• W2884594923 abstract "Knee osteoarthritis (OA) causes substantial pain, physical dysfunction and impaired quality of life. There is no cure for knee OA, and for some people, the disease may involve progressive symptomatic and structural deterioration over time. Platelet-rich plasma (PRP) is a therapeutic agent that aims to address underlying biological processes responsible for OA pathogenesis. As such, it has the potential to improve both symptoms and joint structure. The aim of this clinical trial is to determine whether a series of injections of PRP into the knee joint will lead to a significantly greater reduction in knee pain, and less loss of medial tibial cartilage volume over 12 months when compared to a series of placebo saline injections in people with knee OA. This will be a two-group, superiority, randomised, participant-, interventionist- and assessor-blinded, placebo-controlled trial. Two hundred and eighty-eight participants aged over 50 years with painful knee OA and mild to moderate structural change on x-ray (Kellgren and Lawrence grade 2 and 3) will be randomly allocated to receive either three PRP injections or three normal saline injections into the knee joint at weekly intervals. The primary outcomes will be 12-month change in average overall knee pain severity (numeric rating scale) and medial tibial cartilage volume (magnetic resonance imaging (MRI)). Secondary outcomes include additional measures of knee pain and other symptoms, function in daily living and sport and recreation, quality of life, participant-perceived global ratings of change, and other MRI structural outcomes including meniscal and cartilage morphology, synovitis, effusion, bone marrow lesions and cartilage defects. A range of additional measures will be recorded, and a separate health economic evaluation will be performed. The findings from this study will help determine whether PRP improves both clinical and structural knee OA outcomes over 12 months when compared to a series of placebo saline injections. Australian New Zealand Clinical Trials Registry reference: ACTRN12617000853347 . Prospectively registered 9th of June 2017." @default.
• W2884594923 created "2018-08-03" @default.
• W2884594923 creator A5014653008 @default.
• W2884594923 creator A5017716521 @default.
• W2884594923 creator A5023960003 @default.
• W2884594923 creator A5029772743 @default.
• W2884594923 creator A5034730631 @default.
• W2884594923 creator A5035531287 @default.
• W2884594923 creator A5039609745 @default.
• W2884594923 creator A5047388413 @default.
• W2884594923 creator A5055047226 @default.
• W2884594923 creator A5064527662 @default.
• W2884594923 creator A5065418938 @default.
• W2884594923 creator A5069966705 @default.
• W2884594923 creator A5070677344 @default.
• W2884594923 creator A5071994236 @default.
• W2884594923 creator A5080921373 @default.
• W2884594923 creator A5089856413 @default.
• W2884594923 date "2018-07-28" @default.
• W2884594923 modified "2023-10-14" @default.
• W2884594923 title "Efficacy of intra-articular injections of platelet-rich plasma as a symptom- and disease-modifying treatment for knee osteoarthritis - the RESTORE trial protocol" @default.
• W2884594923 cites W1031259716 @default.
• W2884594923 cites W1492075988 @default.
• W2884594923 cites W1716794597 @default.
• W2884594923 cites W18864370 @default.
• W2884594923 cites W1977317520 @default.
• W2884594923 cites W1978860834 @default.
• W2884594923 cites W1987209737 @default.
• W2884594923 cites W1992564705 @default.
• W2884594923 cites W2011346605 @default.
• W2884594923 cites W2013904927 @default.
• W2884594923 cites W2018004536 @default.
• W2884594923 cites W2025095739 @default.
• W2884594923 cites W2034251536 @default.
• W2884594923 cites W2053507394 @default.
• W2884594923 cites W2076480840 @default.
• W2884594923 cites W2076653261 @default.
• W2884594923 cites W2089619923 @default.
• W2884594923 cites W2103632503 @default.
• W2884594923 cites W2104240789 @default.
• W2884594923 cites W2117011282 @default.
• W2884594923 cites W2117572540 @default.
• W2884594923 cites W2132739775 @default.
• W2884594923 cites W2140513563 @default.
• W2884594923 cites W2141157018 @default.
• W2884594923 cites W2143139033 @default.
• W2884594923 cites W2149781582 @default.
• W2884594923 cites W2154693681 @default.
• W2884594923 cites W2161736885 @default.
• W2884594923 cites W2164434561 @default.
• W2884594923 cites W2166023752 @default.
• W2884594923 cites W2167439117 @default.
• W2884594923 cites W2168342322 @default.
• W2884594923 cites W2170156250 @default.
• W2884594923 cites W2276644929 @default.
• W2884594923 cites W2286191622 @default.
• W2884594923 cites W2407885375 @default.
• W2884594923 cites W2464119509 @default.
• W2884594923 cites W2483159976 @default.
• W2884594923 cites W2582012588 @default.
• W2884594923 cites W2604984760 @default.
• W2884594923 cites W2616167388 @default.
• W2884594923 cites W3022803119 @default.
• W2884594923 cites W4210979010 @default.
• W2884594923 cites W4250933669 @default.
• W2884594923 doi "https://doi.org/10.1186/s12891-018-2205-5" @default.
• W2884594923 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6064619" @default.
• W2884594923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30055602" @default.
• W2884594923 hasPublicationYear "2018" @default.
• W2884594923 type Work @default.
• W2884594923 sameAs 2884594923 @default.
• W2884594923 citedByCount "29" @default.
• W2884594923 countsByYear W28845949232019 @default.
• W2884594923 countsByYear W28845949232020 @default.
• W2884594923 countsByYear W28845949232021 @default.
• W2884594923 countsByYear W28845949232022 @default.
• W2884594923 countsByYear W28845949232023 @default.
• W2884594923 crossrefType "journal-article" @default.
• W2884594923 hasAuthorship W2884594923A5014653008 @default.
• W2884594923 hasAuthorship W2884594923A5017716521 @default.
• W2884594923 hasAuthorship W2884594923A5023960003 @default.
• W2884594923 hasAuthorship W2884594923A5029772743 @default.
• W2884594923 hasAuthorship W2884594923A5034730631 @default.
• W2884594923 hasAuthorship W2884594923A5035531287 @default.
• W2884594923 hasAuthorship W2884594923A5039609745 @default.
• W2884594923 hasAuthorship W2884594923A5047388413 @default.
• W2884594923 hasAuthorship W2884594923A5055047226 @default.
• W2884594923 hasAuthorship W2884594923A5064527662 @default.
• W2884594923 hasAuthorship W2884594923A5065418938 @default.
• W2884594923 hasAuthorship W2884594923A5069966705 @default.
• W2884594923 hasAuthorship W2884594923A5070677344 @default.
• W2884594923 hasAuthorship W2884594923A5071994236 @default.
• W2884594923 hasAuthorship W2884594923A5080921373 @default.
• W2884594923 hasAuthorship W2884594923A5089856413 @default.
• W2884594923 hasBestOaLocation W28845949231 @default.
• W2884594923 hasConcept C126322002 @default.
• W2884594923 hasConcept C141071460 @default.
• W2884594923 hasConcept C142724271 @default.
• W2884594923 hasConcept C159110408 @default.
• W2884594923 hasConcept C168563851 @default.

• next